165 related articles for article (PubMed ID: 11999128)
1. Effect of unilateral nephrectomy on the pharmacokinetics of amikacin in humans.
Drozdzik M; Domanski L; Wojcicki J; Gawronska-Szklarz B; Machoy P; Pudlo A
J Pharm Pharmacol; 2002 Apr; 54(4):509-14. PubMed ID: 11999128
[TBL] [Abstract][Full Text] [Related]
2. Effect of unilateral nephrectomy on the pharmacokinetics of atenolol in humans.
Drozdzik M; Domanski L; Wojcicki J; Pudlo A; Machoy P
J Clin Pharmacol; 2003 May; 43(5):524-8. PubMed ID: 12751273
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of amikacin in lactating sheep.
Haritova A; Lashev L
Vet Res Commun; 2004 Jul; 28(5):429-35. PubMed ID: 15379437
[TBL] [Abstract][Full Text] [Related]
4. An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration.
D'Arcy DM; Casey E; Gowing CM; Donnelly MB; Corrigan OI
BMC Pharmacol Toxicol; 2012 Nov; 13():14. PubMed ID: 23136834
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
Yang RH; Rong XZ; Hua R; Zhang T
Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
[TBL] [Abstract][Full Text] [Related]
6. Correlation of the pharmacokinetic parameters of amikacin and ceftazidime.
Panomvana D; Kiatjaroensin SA; Phiboonbanakit D
Clin Pharmacokinet; 2007; 46(10):859-66. PubMed ID: 17854235
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkey.
Fielding RM; Moon-McDermott L; Lewis RO; Horner MJ
Antimicrob Agents Chemother; 1999 Mar; 43(3):503-9. PubMed ID: 10049258
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of amikacin in lactating goats.
Abo el-Sooud K
Zentralbl Veterinarmed A; 1999 May; 46(4):239-46. PubMed ID: 10399483
[TBL] [Abstract][Full Text] [Related]
9. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
[TBL] [Abstract][Full Text] [Related]
10. [The effect of experimental extrahepatic cholestasis on absorption, distribution and elimination of digoxin].
Wójcicki M
Ann Acad Med Stetin; 1996; 42():51-65. PubMed ID: 9199126
[TBL] [Abstract][Full Text] [Related]
11. A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes.
Bacopoulou F; Markantonis SL; Pavlou E; Adamidou M
J Crit Care; 2003 Jun; 18(2):107-13. PubMed ID: 12800120
[TBL] [Abstract][Full Text] [Related]
12. Diurnal changes in the pharmacokinetic behavior of amikacin.
Bleyzac N; Allard-Latour B; Laffont A; Mouret J; Jelliffe R; Maire P
Ther Drug Monit; 2000 Jun; 22(3):307-12. PubMed ID: 10850398
[TBL] [Abstract][Full Text] [Related]
13. Amikacin pharmacokinetics and the effects of ambient temperature on the dosage regimen in ball pythons (Python regius).
Johnson JH; Jensen JM; Brumbaugh GW; Boothe DM
J Zoo Wildl Med; 1997 Mar; 28(1):80-8. PubMed ID: 9226620
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults.
Tod M; Lortholary O; Seytre D; Semaoun R; Uzzan B; Guillevin L; Casassus P; Petitjean O
Antimicrob Agents Chemother; 1998 Apr; 42(4):849-56. PubMed ID: 9559795
[TBL] [Abstract][Full Text] [Related]
15. Single-Dose Pharmacokinetics and Safety of Meropenem-Vaborbactam in Subjects with Chronic Renal Impairment.
Rubino CM; Bhavnani SM; Loutit JS; Lohse B; Dudley MN; Griffith DC
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311069
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of population pharmacokinetics with NONMEM in clinical patients treated with amikacin by intravenous infusion].
Chu XM; Rui JZ; Zhou YG; Dai YJ; Cai WM; Ling SS
Yao Xue Xue Bao; 1996; 31(12):881-5. PubMed ID: 9863218
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of renal function equations to predict amikacin clearance.
Sáez Fernández EM; Pérez-Blanco JS; Lanao JM; Calvo MV; Martín-Suárez A
Expert Rev Clin Pharmacol; 2019 Aug; 12(8):805-813. PubMed ID: 31242039
[No Abstract] [Full Text] [Related]
18. Comparison of amikacin pharmacokinetics in a killer whale (Orcinus orca) and a beluga whale (Delphinapterus leucas).
KuKanich B; Papich M; Huff D; Stoskopf M
J Zoo Wildl Med; 2004 Jun; 35(2):179-84. PubMed ID: 15305513
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and renal toxicity of three once-a-day doses of amikacin in cows.
Sumano H; Gutierrez L; Velazquez C; Hayashida S
Acta Vet Hung; 2005; 53(2):231-40. PubMed ID: 15959981
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacokinetics of amikacin in Greyhound and Beagle dogs.
KuKanich B; Coetzee JF
J Vet Pharmacol Ther; 2008 Apr; 31(2):102-7. PubMed ID: 18307501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
